Yabao Pharmaceutical Group Co Ltd (600351) — Capital Reinvestment Ratio
Yabao Pharmaceutical Group Co Ltd (600351) has a Capital Reinvestment Ratio of 0.06x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥129.49 Million) in capital expenditures (CN¥7.58 Million). See Yabao Pharmaceutical Group Co Ltd (600351) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Yabao Pharmaceutical Group Co Ltd Capital Reinvestment Ratio (2001–2024)
This chart tracks Yabao Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 22 annual periods. Check Yabao Pharmaceutical Group Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Yabao Pharmaceutical Group Co Ltd (2001–2024)
Year-by-year Capital Reinvestment Ratio for Yabao Pharmaceutical Group Co Ltd from 2001 to 2024. For live market cap and broader valuation context, see 600351 market cap overview.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.07x | CN¥471.69 Million | CN¥34.66 Million | ▼ -63.4% |
| 2023 | 0.20x | CN¥497.55 Million | CN¥99.86 Million | ▲ +48.5% |
| 2022 | 0.14x | CN¥460.46 Million | CN¥62.23 Million | ▼ -37.8% |
| 2021 | 0.22x | CN¥437.50 Million | CN¥95.05 Million | ▲ +31.7% |
| 2020 | 0.17x | CN¥380.96 Million | CN¥62.87 Million | ▼ -55.3% |
| 2019 | 0.37x | CN¥425.17 Million | CN¥157.09 Million | ▲ +131.8% |
| 2018 | 0.16x | CN¥426.60 Million | CN¥68.01 Million | ▼ -74.0% |
| 2017 | 0.61x | CN¥161.73 Million | CN¥99.34 Million | ▲ +13.4% |
| 2016 | 0.54x | CN¥155.95 Million | CN¥84.46 Million | ▼ -23.6% |
| 2015 | 0.71x | CN¥143.47 Million | CN¥101.68 Million | ▼ -27.2% |
| 2014 | 0.97x | CN¥178.63 Million | CN¥173.84 Million | ▼ -44.2% |
| 2013 | 1.74x | CN¥56.80 Million | CN¥99.02 Million | ▼ -40.6% |
| 2011 | 2.94x | CN¥40.73 Million | CN¥119.56 Million | ▼ -70.9% |
| 2010 | 10.09x | CN¥18.57 Million | CN¥187.30 Million | ▲ +1278.1% |
| 2009 | 0.73x | CN¥368.56 Million | CN¥269.82 Million | ▼ -48.9% |
| 2008 | 1.43x | CN¥102.90 Million | CN¥147.56 Million | ▲ +384.1% |
| 2007 | 0.30x | CN¥105.69 Million | CN¥31.31 Million | ▼ -92.1% |
| 2006 | 3.77x | CN¥11.59 Million | CN¥43.70 Million | ▼ -8.7% |
| 2005 | 4.13x | CN¥26.40 Million | CN¥108.95 Million | ▲ +62.3% |
| 2004 | 2.54x | CN¥79.73 Million | CN¥202.81 Million | ▲ +125.7% |
| 2002 | 1.13x | CN¥24.29 Million | CN¥27.38 Million | ▲ +15.4% |
| 2001 | 0.98x | CN¥23.59 Million | CN¥23.04 Million | — |